Andlauer Healthcare Group (TSE:AND) Given New C$54.00 Price Target at TD Securities

Andlauer Healthcare Group logo with Industrials background

Andlauer Healthcare Group (TSE:AND - Free Report) had its target price raised by TD Securities from C$52.00 to C$54.00 in a research report released on Thursday morning, BayStreet.CA reports. They currently have a buy rating on the stock.

A number of other research analysts also recently weighed in on the stock. Scotiabank upped their price objective on shares of Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the stock a sector perform rating in a research report on Thursday, March 7th. Royal Bank of Canada upped their price target on shares of Andlauer Healthcare Group from C$41.00 to C$43.00 and gave the stock a sector perform rating in a research report on Thursday, March 7th. CIBC upped their price target on shares of Andlauer Healthcare Group from C$50.00 to C$52.00 and gave the stock an outperform rating in a research report on Thursday, March 7th. Eight Capital dropped their price objective on shares of Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating for the company in a research note on Thursday, March 7th. Finally, National Bankshares upped their price objective on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the company a sector perform rating in a research note on Thursday, March 7th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of C$50.93.


View Our Latest Stock Analysis on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Performance

TSE:AND traded up C$0.42 during mid-day trading on Thursday, hitting C$42.06. The company's stock had a trading volume of 10,396 shares, compared to its average volume of 27,098. Andlauer Healthcare Group has a 1 year low of C$36.76 and a 1 year high of C$52.55. The company has a debt-to-equity ratio of 27.24, a current ratio of 2.52 and a quick ratio of 1.66. The stock has a market cap of C$819.33 million, a price-to-earnings ratio of 27.04 and a beta of 0.69. The business's fifty day moving average is C$41.55 and its two-hundred day moving average is C$40.34.

Andlauer Healthcare Group (TSE:AND - Get Free Report) last posted its quarterly earnings results on Tuesday, March 5th. The company reported C$0.44 EPS for the quarter, missing the consensus estimate of C$0.49 by C($0.05). The business had revenue of C$169.07 million during the quarter, compared to analysts' expectations of C$165.00 million. Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. Analysts anticipate that Andlauer Healthcare Group will post 1.8453564 EPS for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Thursday, March 28th were issued a dividend of $0.10 per share. The ex-dividend date was Wednesday, March 27th. This is a positive change from Andlauer Healthcare Group's previous quarterly dividend of $0.09. This represents a $0.40 dividend on an annualized basis and a yield of 0.95%. Andlauer Healthcare Group's dividend payout ratio is 23.23%.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

→ Is this Nvidia's secret weapon? (From Manward Press) (Ad)

Should you invest $1,000 in Andlauer Healthcare Group right now?

Before you consider Andlauer Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.

While Andlauer Healthcare Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Search Headlines: